pd 98059 has been researched along with Osteoarthritis, Knee in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Manner, PA | 1 |
| Horner, A | 1 |
| Shum, L | 1 |
| Tuan, RS | 1 |
| Nuckolls, GH | 1 |
1 other study available for pd 98059 and Osteoarthritis, Knee
| Article | Year |
|---|---|
Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage.
Topics: Animals; Blotting, Western; Butadienes; Cartilage, Articular; Case-Control Studies; Cattle; Cells, C | 2004 |